Effects of Activity on Diabetes Risk Among Breast Cancer Survivors on Endocrine Therapy (ABIDE)

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

February 14, 2022

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions
Breast Cancer
Interventions
OTHER

No intervention

No intervention is performed. Participants who have been treated with either a SERM or aromatase inhibitor are recruited and analyzed in separate groups, but the study design for all participants is identical.

Trial Locations (1)

80045

University Of Colorado Anschutz Medical Campus, Aurora

All Listed Sponsors
collaborator

Colorado State University

OTHER

lead

University of Colorado, Denver

OTHER